Mai Osman Mohamed Kadry | Biochemistry | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Mai Osman Mohamed Kadry | Biochemistry | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry,National Research Center, Egypt

Dr. Mai Osman Mohamed Kadry is a distinguished biochemistry researcher at the Therapeutic Chemistry Department, National Research Centre, Egypt. With a Doctorate in Biochemistry from Cairo University (2016), her work focuses on oxidative injury, nanotoxicity, and cancer therapy. She has published extensively in high-impact journals on topics like antioxidant effects, stem cell therapies, and metabolic disorders. Dr. Kadry has also contributed to academia, teaching pharmacognosy at 6th October University. Skilled in advanced techniques like PCR, HPLC, and ELISA, she actively participates in groundbreaking nanobiotechnology research projects. Dr. Kadry is committed to advancing therapeutic strategies for critical diseases. 📚🧬

Profile

🎓 Education

Assist. Prof. Dr. Mai O. Kadry boasts a strong academic foundation in pharmaceutical sciences. She earned her Doctorate in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a thesis on the “Amelioration of Nano-Sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She obtained her Master’s degree in Pharmaceutical Sciences from Helwan University in 2008, focusing on the synergistic effects of phytic and catechin on carbon tetrachloride-induced damage in rats. Dr. Kadry completed her B.Sc. in Pharmaceutical Science at Ain Shams University in 2003, graduating with honors. She also attended English language schools, enhancing her global communication skills. 🌟🔬

🧪 Experience

Assist. Prof. Dr. Mai O. Kadry has accumulated valuable experience in academia and research. She served as a pharmacognosy instructor at the Faculty of Pharmacy, 6th October University, Cairo, Egypt (2003–2004), where she effectively delivered courses on natural products and their therapeutic applications. Dr. Kadry also contributed as a staff member focused on development and quality enhancement, aligning with the standards of the National Commission for Academic Accreditation. Her dedication to education and quality assurance reflects her commitment to fostering academic excellence and professional growth in pharmaceutical sciences. 📚🔬

Training 🧬📚

Assist. Prof. Dr. Mai O. Kadry has undergone extensive training in various scientific disciplines. She completed courses in Biostatistics (November 2016) and Bioinformatics (January 2017) at the National Research Centre. Earlier, she gained expertise in Scientific Typewriting Bases (March 2007) and Occupational Health and Safety (June 2009). Additionally, she mastered Protein Electrophoresis through a four-month course in 2006. Dr. Kadry enhanced her practical skills with hands-on training at Al-Borg Clinical Laboratory, focusing on PCR techniques for detecting HBV and HCV at the Theodor Bilharz Research Institute. Her comprehensive training equips her with valuable laboratory and analytical skills. 🔬🧪

🔬 Research Focus

Assist. Prof. Dr. Mai O. Kadry focuses on cutting-edge biomedical research, emphasizing toxicity, cancer therapy, and molecular biology. Her work explores inflammatory mediators, DNA damage, and therapeutic approaches in liver, brain, and nephrotoxicity contexts. She investigates autophagy, necroptosis, and novel strategies like resveratrol nano-formulations for ovarian cancer. Dr. Kadry also studies molecular pathways in gastric and prostate cancers, including miRNA-lncRNA signaling and CRISPR-Cas9 applications. Other interests involve genetic mutations in leukemia, drug-delivery systems, and nanotechnology for breast cancer. Her contributions bridge diagnostics, therapeutic innovations, and cellular mechanisms in oncology and toxicology. 🔬✨

✅ Conclusion

Assist. Prof. Dr. Mai O. Kadry is a distinguished biochemistry researcher whose work bridges advanced molecular biology and therapeutic innovation. With expertise in nanotoxicity, oxidative injury, and cancer therapy, she contributes significantly to biomedical science through impactful research and academic leadership. Her training in cutting-edge techniques and her focus on translational medicine position her at the forefront of scientific discovery. Dr. Kadry’s dedication to improving healthcare through targeted therapies and her commitment to academic excellence make her a valuable asset to the scientific community. Her career reflects passion, innovation, and a relentless pursuit of better treatment solutions.

 

Publications

  • Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study

    Future Science OA
    2024-12-31 | Journal article
    DOI: 10.2144/fsoa-2023-0111
    CONTRIBUTORS: Mai O Kadry; Abdel-Hamid Z Abdel Hamid; Rehab M Abdel-Megeed

  • Fischer’s oligopeptide ratio in ischemic hypoxia: prophylactic amendment of sophoretin and melatonin supplementation

    Future Science OA
    2024-12-31 | Journal article
    DOI: 10.2144/fsoa-2023-0117
    CONTRIBUTORS: Mai O Kadry; Hanaa Mahmoud Al

  • Thioctic acid shield against lipopolysaccharide depression and endoplasmic reticulum stress: GR7M/Homer/ATF6 signaling

    Future Science OA
    2024-12-31 | Journal article
    DOI: 10.1080/20565623.2024.2422791
    CONTRIBUTORS: Mai O. Kadry; Rehab M. Abdel-Megee

PhongSon Dinh | Gene function analysis | Best Researcher Award

Posted on by sciencefather

Dr. PhongSon Dinh | Gene function analysis | Best Researcher Award

Dr. Dinh Phong Son is a prominent researcher at Duy Tan University, Vietnam, specializing in laboratory medicine and molecular medicine. With a PhD from Guangxi Medical University, China, he is dedicated to advancing the field of molecular biology and medical diagnostics. His work focuses on identifying biomarkers for early disease detection and investigating gene targets for targeted therapies. He actively contributes to scientific advancements in understanding complex diseases such as cancer, diabetes, and cardiovascular diseases. Through his expertise in molecular techniques like CRISPR/Cas9, PCR, and sequencing, Dr. Son plays a vital role in improving medical diagnostics and treatments. 🧬🔬

Profile

Education 🎓

Dr. Dinh Phong Son holds a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China, after earning his degree in Laboratory Medicine from Hue University of Medicine and Pharmacy, Vietnam. His educational background has equipped him with the expertise in molecular biology, enabling him to explore complex diseases at a molecular level and work on cutting-edge technologies in the field of gene editing and disease diagnosis. 🎓📚

Experience 👨‍🏫

Dr. Dinh Phong Son has significant experience in molecular medicine, focusing on the development of biomarkers for early disease diagnosis and treatment. With expertise in molecular biology techniques such as PCR, qPCR, CRISPR/Cas9, and sequencing, he has conducted extensive research on diseases like cancer, cardiovascular disorders, and diabetes. His work integrates bioinformatics and molecular assays to understand gene functions and identify potential drug targets. He is actively contributing to scientific publications and advancing the research community’s knowledge in disease diagnostics and therapies. 🔬💡

Research Interests 🔬

Dr. Dinh Phong Son’s research focuses on molecular techniques for disease detection and gene therapy. His current work includes exploring circRNA, miRNA, mRNA, and their role in diseases like coronary heart disease and cancer. Dr. Son is particularly interested in developing diagnostic biomarkers and therapeutic targets for systemic diseases using next-generation sequencing and CRISPR/Cas9. He also investigates the interaction networks between lncRNA, circRNA, miRNA, genes, and proteins, aiming to create molecular-based solutions for precision medicine. His research paves the way for future advancements in molecular diagnostics and personalized therapies. 🔬🧬

Awards & Recognitions 🏅

Dr. Dinh Phong Son’s contributions to molecular medicine have earned him recognition in the scientific community. His research publications, particularly on gene networks and biomarkers in cardiovascular and cancer research, have garnered widespread attention. He is currently a nominee for the Best Researcher Award, reflecting his ongoing commitment to advancing the fields of molecular biology, gene therapy, and disease diagnostics. His work is an important step toward improving public health outcomes through the application of molecular techniques. 🏆🏅

Publications 📚

  • Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation

    Biochemistry and Biophysics Reports
    2025-03 | Journal article
    DOI: 10.1016/j.bbrep.2025.101952
    CONTRIBUTORS: PhongSon Dinh; ChauMyThanh Tran; ThiPhuongHoai Dinh; Hai-Anh Ha; Aigul Utegenova; Awais Ali; Abdulaziz Alamri

  • Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1

    Journal of Biomolecular Structure and Dynamics
    2024-07-02 | Journal article
    DOI: 10.1080/07391102.2023.2225109
    CONTRIBUTORS: PhongSon Dinh; ChauMyThanh Tran; ThiPhuongHoai Dinh; Awais Ali; ShangLing Pan

  • Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data

    Journal of Biomolecular Structure and Dynamics
    2024-03-15 | Journal article
    DOI: 10.1080/07391102.2024.2328744
    CONTRIBUTORS: ChauMyThanh Tran; PhongSon Dinh

  • Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease

    Frontiers in Cardiovascular Medicine
    2023-03-14 | Journal article
    DOI: 10.3389/fcvm.2023.1104223
    Part of ISSN: 2297-055X
    CONTRIBUTORS: PhongSon Dinh; JunHua Peng; ThanhLoan Tran; DongFeng Wu; ChauMyThanh Tran; ThiPhuongHoai Dinh; ShangLing Pan

Lekshmi K. Edison | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Dr.Lekshmi K. Edison | Molecular Biology| Best Researcher Award

 

University of Florida, United States

Profile

Education

She earned her Ph.D. in Biotechnology from the University of Kerala, India, in 2019. Prior to that, she completed a Master’s in Biotechnology from Mahatma Gandhi University in 2006 and an undergraduate degree in Zoology from the same university in 2004. Additionally, she holds a Master’s Diploma in Bioinformatics from Bharathiyar University (2015) and a Diploma in Computer Application from C-Dit, India (2014).

Work experience

She is currently a Postdoctoral Associate at the College of Veterinary Medicine, University of Florida, Gainesville, FL, United States, a position she has held since 2022. Prior to this, she worked as a Postdoctoral Associate at the College of Medicine, University of Florida, from 2021 to 2022. From 2019 to 2021, she served as a Postdoctoral Research Associate at the Rajiv Gandhi Centre for Biotechnology in Thiruvananthapuram, Kerala, India. Earlier in her career, she was a Research Fellow at KSCSTE-JNTBGRI, Palode, Kerala, from 2015 to 2019, and a Project Fellow at the Department of Plant Physiology, College of Agriculture, Vellayani, Kerala, from 2011 to 2013.

Awards

She has received several prestigious honors and awards throughout her career. In 2024, she was awarded the UF Postdoctoral Affairs Spring 2024 Travel Award by the University of Florida and the American Society of Microbiology (ASM) Future Leaders Mentorship Fellowship (FLMF). In 2023, she received the American Society of Virology Postdoctoral Scholar Travel Award. Earlier, she was honored with the Department of Biotechnology-Research Associateship Program Fellowship from the Government of India in 2019. Additionally, she received the Women Scientist’s Back to Lab Research Fellowship from the State Government of Kerala, India, in 2015, and qualified for the National Eligibility Test for Lectureship conducted by the Indian Council of Agricultural Research, Government of India, in 2014.

 OTHER PROFESSIONAL CREDENTIALS (LICENSURE, CERTIFICATION, ETC)

She has obtained multiple professional certifications and training credentials. In 2024, she completed the HiPerGator Account Training at the University of Florida, along with certifications in NIH Recombinant DNA (rDNA) and Nanoparticle Biosafety/Biosecurity through CITI. She also received training from the American Association for Laboratory Animal Science (AALAS) in areas such as working safely with rabbits and ferrets in biocontainment and working with laboratory rats. In 2023, she completed the Life Sciences Responsible Conduct of Research Course, training on COVID-19 vaccine research, and multiple AALAS certifications, including working with the IACUC and poultry in laboratories. Earlier, in 2021, she acquired certifications in laboratory animal science, pain management in research animals, and post-procedure care for mice and rats.

Book Edited

  •  Pradeep NS, Edison LK (Editors). 2022. Microbial Beta Glucanases – Molecular
    Structure, Functions and Applications. In Book Series: Interdisciplinary
    Biotechnological Advances. Springer Nature Singapore Pte Ltd., Pages 206. DOI
    https://doi.org/10.1007/978-981-19-6466-4, ISBNs 978-981-196465-7 (Hard cover),
    978-981-196466-4 (eBook).

Book chapters

  • Edison LK, Pradeep NS. Isolation of beta-glucanase encoding genes from actinobacterial
    genus Streptomyces spp. and its overexpression in Escherichia coli heterologous system. In:
    Karthik L, ed. Protocols of Actinomycetes: Microbiology to Gene Editing. 1st ed. Boca Raton,
    FL: CRC Press; 2024:Chapter 11. doi:10.1201/9781003398400-11
  • Nair S, Sahay B, Arukha AP, Edison LK, Crews CD, Morris JG Jr, Kariyawasam S,
    Yamamoto JK. Interferon-γ/IL-2 ELISpot and mRNA Responses to the SARS-CoV2, Feline
    Coronavirus Serotypes 1 (FCoV1), and FCoV2 Receptor Binding Domains by the T Cells
    from COVID-19-Vaccinated Humans and FCoV1-Infected Cats. Methods Mol Biol.
    2024;2768:135-151. doi: 10.1007/978-1-0716-3690-9_9.
  • Ragitha VM, Edison LK. Safety issues, environmental impacts, and health effects of
    Biopolymers. In: Thomas S, Ar A, Jose Chirayil C, Thomas B, eds. Handbook of Biopolymers.
    Springer; 2022. doi:10.1007/978-981-16-6603-2_54-1.

Publication